Patents by Inventor Michael L. Jones
Michael L. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11980363Abstract: A surgical stapling assembly is disclosed. The assembly can include a cartridge body having cavities defined therein forming a pattern of openings in the deck of the cartridge body. The pattern can include longitudinally-repeating clusters of cavity ends. The assembly can also include fasteners removably positioned in the cavities. The pattern of openings can comprise openings on a first side of the cartridge body comprising inner openings each defining an inner proximal-to-distal axis oriented parallel to the longitudinal axis, outer openings each defining an outer proximal-to-distal axis obliquely-oriented relative to the longitudinal axis at an outer angle, and intermediate openings each defining an intermediate proximal-to-distal axis obliquely-oriented relative to the longitudinal axis at an intermediate angle, wherein the intermediate angle is different than the outer angle.Type: GrantFiled: October 18, 2021Date of Patent: May 14, 2024Assignee: Cilag GmbH InternationalInventors: Michael J. Stokes, Anil K. Nalagatla, Mark S. Zeiner, Chester O. Baxter, III, Disha V. Estera, Jason L. Harris, Laura S. Downing, Shannon L. Jones
-
Patent number: 11963975Abstract: The disclosure relates to methods and compositions for regulating expression of DUX4. In some aspects, methods described by the disclosure are useful for treating a disease associated with aberrant DUX4 expression (e.g., facioscapulohumeral muscular dystrophy).Type: GrantFiled: September 30, 2021Date of Patent: April 23, 2024Assignee: University of MassachusettsInventors: Peter L. Jones, Michael R. Green
-
Publication number: 20240098234Abstract: A head-mounted device is provided that includes one or more cameras configured to acquire a raw video feed and one or more displays configured to present a passthrough video feed to a user. Generation of the passthrough video feed can involve processing the raw video feed using an image signal processor and auxiliary compute blocks. One or more of the auxiliary compute blocks can be bypassed in response to detecting one or more failures associated with the auxiliary compute blocks. Configured and operated in this way, the head-mounted device can fall back to a more reliable passthrough video feed without having to power cycle the head-mounted device when a failure occurs.Type: ApplicationFiled: September 6, 2023Publication date: March 21, 2024Inventors: Michael C Friedman, Russell L Jones, Kaushik Raghunath, Venu M Duggineni, Ranjit Desai, Manjunath M Venkatesh, Michael J Rockwell, Arun Kannan, Saul H Weiss
-
Publication number: 20240094233Abstract: The present invention relates to methods, devices and systems for associating consumable data with an assay consumable used in a biological assay. Provided are assay systems and associated consumables, wherein the assay system adjusts one or more steps of an assay protocol based on consumable data specific for that consumable. Various types of consumable data are described, as well as methods of using such data in the conduct of an assay by an assay system. The present invention also relates to consumables (e.g., kits and reagent containers), software, data deployable bundles, computer-readable media, loading carts, instruments, systems, and methods, for performing automated biological assays.Type: ApplicationFiled: July 18, 2023Publication date: March 21, 2024Inventors: Jacob N. WOHLSTADTER, Manish KOCHAR, Peter J. BOSCO, Ian D. CHAMBERLIN, Bandele JEFFREY-COKER, Eric M. JONES, Gary I. KRIVOY, Don E. KRUEGER, Aaron H. LEIMKUEHLER, Pei-Ming WU, Kim-Xuan NGUYEN, Pankaj OBEROI, Louis W. PANG, Jennifer PARKER, Victor PELLICIER, Nicholas SAMMONS, George SIGAL, Michael L. VOCK, Stanley T. SMITH, Carl C. STEVENS, Rodger D. OSBORNE, Kenneth E. PAGE, Michael T. WADE, Jon WILLOUGHBY, Lei WANG, Xinri CONG, Kin NG
-
Publication number: 20240008898Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.Type: ApplicationFiled: September 22, 2023Publication date: January 11, 2024Applicant: Indian Wells Medical, Inc.Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
-
Patent number: 11844548Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.Type: GrantFiled: September 22, 2023Date of Patent: December 19, 2023Assignee: Indian Wells Medical, Inc.Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
-
Patent number: 11833275Abstract: A method for forming a porous implant suitable for a cavity from which tissue has been removed includes incorporating a gas or a pore forming agent into an alginate solution; transferring the alginate solution with the gas or the pore forming agent into a solidified body mold having a desired shape with an outer surface; removing the water from the solidified body; and subjecting the solidified body to a conversion solution to convert the outer surface to a less soluble alginate creating a composition comprising the outer surface having less soluble alginate and a core having more soluble alginate.Type: GrantFiled: September 1, 2020Date of Patent: December 5, 2023Assignee: SenoRx, Inc.Inventors: Amit Govil, Michael L. Jones, Paul Lubock
-
Patent number: 11771463Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.Type: GrantFiled: September 22, 2020Date of Patent: October 3, 2023Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
-
Publication number: 20230208813Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. Based at least in part on the combined measure of risk associated with the message, a verification action is performed including by automatically providing an inquiry message that requests a response to be provided.Type: ApplicationFiled: February 27, 2023Publication date: June 29, 2023Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
-
Patent number: 11595354Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. Based at least in part on the combined measure of risk associated with the message, a verification action is performed including by automatically providing an inquiry message that requests a response to be provided.Type: GrantFiled: March 19, 2021Date of Patent: February 28, 2023Assignee: Agari Data, Inc.Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
-
Patent number: 11354635Abstract: Systems and methods for providing a payment messaging interface may include receiving, at a computing device comprising a processor, transaction information regarding the transaction. Once the transaction information is received, the transaction information may be translated into a data structure that corresponds to a payment processor. Once the transaction information has been translated, the data structure may be transmitted to the payment processor.Type: GrantFiled: September 28, 2017Date of Patent: June 7, 2022Assignee: NCR CorporationInventors: Michael L. Jones, Carl L. Best
-
Publication number: 20210211411Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. Based at least in part on the combined measure of risk associated with the message, a verification action is performed including by automatically providing an inquiry message that requests a response to be provided.Type: ApplicationFiled: March 19, 2021Publication date: July 8, 2021Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
-
Patent number: 10992645Abstract: At least one of a measure of trust or a measure of spoofing risk associated with a sender of a message is determined. A measure of similarity between an identifier of the sender of the message and an identifier of at least one trusted contact of a recipient of the message is determined. The measure of similarity is combined with at least one of the measure of trust or the measure of spoofing risk to at least in part determine a combined measure of risk associated with the message. The sender of the message is not included in the at least one trusted contact of the recipient of the message. Based at least in part on the combined measure of risk associated with the message, the message is modified to alter content of a data field that includes an identification of the sender of the message.Type: GrantFiled: April 30, 2019Date of Patent: April 27, 2021Assignee: Agari Data, Inc.Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
-
Publication number: 20210105252Abstract: A first risk analysis of a message is performed. In the event the first risk analysis results in a determination that the message meets a first criteria, at least a portion of the message is modified prior to sending a modified version of the message to a specified recipient of the message, and a second risk analysis of the message is performed. The first risk analysis is performed before sending the modified version of the message and the modified version of the message is sent to the specified recipient of the message prior to a conclusion of the second risk analysis. In the event the second risk analysis results in a determination that the message meets a second criteria, content of the message that was previously prevented from being accessed by the specified recipient is provided to the specified recipient of the message.Type: ApplicationFiled: July 28, 2020Publication date: April 8, 2021Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
-
Publication number: 20210023278Abstract: A method for forming a porous implant suitable for a cavity from which tissue has been removed includes incorporating a gas or a pore forming agent into an alginate solution; transferring the alginate solution with the gas or the pore forming agent into a solidified body mold having a desired shape with an outer surface; removing the water from the solidified body; and subjecting the solidified body to a conversion solution to convert the outer surface to a less soluble alginate creating a composition comprising the outer surface having less soluble alginate and a core having more soluble alginate.Type: ApplicationFiled: September 1, 2020Publication date: January 28, 2021Inventors: Amit Govil, Michael L. Jones, Paul Lubock
-
Publication number: 20210000505Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.Type: ApplicationFiled: September 22, 2020Publication date: January 7, 2021Applicant: Indian Wells Medical, Inc.Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
-
Patent number: 10805270Abstract: A first risk analysis of a message is performed. In the event the first risk analysis results in a determination that the message meets a first criteria, at least a portion of the message is modified prior to sending a modified version of the message to a specified recipient of the message, and a second risk analysis of the message is performed. The first risk analysis is performed before sending the modified version of the message and the modified version of the message is sent to the specified recipient of the message prior to a conclusion of the second risk analysis. In the event the second risk analysis results in a determination that the message meets a second criteria, content of the message that was previously prevented from being accessed by the specified recipient is provided to the specified recipient of the message.Type: GrantFiled: March 8, 2017Date of Patent: October 13, 2020Assignee: Agari Data, Inc.Inventors: Bjorn Markus Jakobsson, Theodore C. Loder, Jacob R. Rideout, Arthur Kwan Jakobsson, Michael L. Jones
-
Patent number: 10786604Abstract: In one form, the invention is directed to a method for forming a porous implant suitable for a cavity from which tissue has been removed, including mixing soluble alginate and a radiopaque imaging agent with water; incorporating a gas or a pore forming agent into the alginate-water mixture; transferring the alginate-water mixture with the gas or the pore forming agent into a mold to form the mixture into a solid body of desired shape; removing the water from the body; and converting at least part of the soluble alginate to a less soluble alginate. In another form, the invention includes forming a mixture by mixing about 0.5 percent to about 4 percent by weight chitosan into an acidified aqueous solution containing 1 percent to 25 percent by weight acetic acid, along with about 0.5 percent to about 5 percent by weight of a powdered radiopaque imaging agent.Type: GrantFiled: May 7, 2014Date of Patent: September 29, 2020Assignee: SenoRx, Inc.Inventors: Amit Govil, Michael L. Jones, Paul Lubock
-
Patent number: 10779858Abstract: An endoluminal needle or punch is describes wherein the distal end of the endoluminal needle is able to articulate laterally out of the longitudinal axis of the steerable endoluminal needle. The endoluminal needle further comprise a blunted distal end configuration that is minimally traumatic. Under control by the user, at the proximal end of the endoluminal needle, a sharp stylet can be advanced to punch tissue and then be retracted to maximize safety. The endoluminal needle is configured for use within an introducer.Type: GrantFiled: June 7, 2018Date of Patent: September 22, 2020Assignee: Indian Wells Medical, Inc.Inventors: Jay A. Lenker, Michael L. Jones, James A. Carroll
-
Patent number: 10413750Abstract: The disclosure describes devices and methods for asymmetrical irradiation at a body cavity or site, such as after removal of tissue, e.g. biopsy or cancer. One device includes a lumen which is off-set or off-settable from a longitudinal axis to increase the intensity of radiation received from a radiation source by a first tissue portion surrounding the body cavity and to reduce or minimize radiation received by a second tissue portion (e.g. healthy tissue) surrounding the body cavity.Type: GrantFiled: August 12, 2016Date of Patent: September 17, 2019Assignee: HOLOGIC, INC.Inventors: Paul Lubock, Michael L. Jones, Frank R. Louw